Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | — | — |
No symptoms reported. No additional adverse event reported.; adult patient who was inadvertently administered a pediatric dose of RECOMBIVAXHB; This spontaneous report was received from a certified medical assistant and refers to an adult patient of an unknown gender. No information regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies. On 19-FEB-2025, the patient was inadvertently administered a pediatric dose of hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) injection, 0.5 ml for prophylaxis (lot #, expiration date, route and site of administration were not provided). No symptoms reported. No additional adverse event reported.